Systematic review and cost‐utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia

Nasal Continuous Positive Airway Pressure (CPAP) and High‐Flow Nasal Cannula (HFNC) have emerged as alternatives to orotracheal intubation and conventional invasive ventilation in patients with moderate to severe bronchiolitis. This study aims to evaluate the evidence and the cost‐utility of HFNC compared to CPAP in infants with moderate‐severe bronchiolitis in Colombia.

[1]  P. Rodriguez-Lesmes,et al.  Estimating Cost-Effectiveness Thresholds Under a Managed Healthcare System: Experiences from Colombia. , 2021, Health policy and planning.

[2]  Diana Guerrero Patiño,et al.  Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia , 2021, Expert review of pharmacoeconomics & outcomes research.

[3]  Xiaolong Zhang,et al.  Non-Invasive Ventilation Strategies in Children With Acute Lower Respiratory Infection: A Systematic Review and Bayesian Network Meta-Analysis , 2021, Frontiers in Pediatrics.

[4]  J. Buendía,et al.  Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma , 2021, BMC Pulmonary Medicine.

[5]  N. Ghali,et al.  High flow nasal cannula therapy versus continuous positive airway pressure and nasal positive pressure ventilation in infants with severe bronchiolitis: a randomized controlled trial , 2021, The Pan African medical journal.

[6]  J. Buendía,et al.  Cost-utility of azithromycin in patients with severe asthma , 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

[7]  J. Buendía,et al.  Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma. , 2021, Pediatric pulmonology.

[8]  S. Kotecha,et al.  Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis , 2021, BMJ Open Respiratory Research.

[9]  C. Rodríguez‐Martínez,et al.  Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective , 2021, Current medical research and opinion.

[10]  Jilei Lin,et al.  The Effects and Safety of Continuous Positive Airway Pressure in Children with Bronchiolitis: A Systematic Review and Meta-Analysis. , 2021, Journal of tropical pediatrics.

[11]  J. Buendía,et al.  Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective , 2021, BMC Health Services Research.

[12]  I. Flórez,et al.  Continuous Positive Airway Pressure vs. High Flow Nasal Cannula in children with acute severe or moderate bronchiolitis. A systematic review and Meta-analysis. , 2020, Medicina intensiva.

[13]  C. Rodríguez‐Martínez,et al.  The cost-utility of early use of high-flow nasal cannula in bronchiolitis , 2020, Health Economics Review.

[14]  C. Rodríguez‐Martínez,et al.  The cost‐utility of intravenous magnesium sulfate for treating asthma exacerbations in children , 2020, Pediatric pulmonology.

[15]  J. Buendía,et al.  The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis , 2020, BMC Health Services Research.

[16]  C. Rodríguez‐Martínez,et al.  Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma , 2020, Cost Effectiveness and Resource Allocation.

[17]  J. Buendía,et al.  Costs of Respiratory Syncytial Virus Hospitalizations in Colombia , 2020, PharmacoEconomics - Open.

[18]  A. Rotta,et al.  High-Flow Nasal Cannula versus Continuous Positive Airway Pressure in Critical Bronchiolitis: A Randomized Controlled Pilot , 2020, Journal of Pediatric Intensive Care.

[19]  P. Kofoed,et al.  High flow nasal cannula and continuous positive airway pressure therapy in treatment of viral bronchiolitis: a randomized clinical trial , 2019, European Journal of Pediatrics.

[20]  B. Manley,et al.  Cost‐Effectiveness Analysis of Nasal Continuous Positive Airway Pressure Versus Nasal High Flow Therapy as Primary Support for Infants Born Preterm , 2018, The Journal of pediatrics.

[21]  M. Sarkar,et al.  Comparative Study between Noninvasive Continuous Positive Airway Pressure and Hot Humidified High-flow Nasal Cannulae as a Mode of Respiratory Support in Infants with Acute Bronchiolitis in Pediatric Intensive Care Unit of a Tertiary Care Hospital , 2018, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[22]  G. Cambonie,et al.  High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study) , 2017, Intensive Care Medicine.

[23]  A. Culyer.  Net Monetary Benefit , 2014 .

[24]  C. Rodríguez‐Martínez,et al.  Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region , 2014, Pediatric pulmonology.

[25]  S. Essouri,et al.  Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy , 2013, Intensive Care Medicine.

[26]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[27]  A. Carroll,et al.  Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. , 2009, The Journal of pediatrics.

[28]  Virginia Ghiglione,et al.  Tema De Fondo - La secuela de manipular el Índice de Precios al Consumidor (IPC) , 2008 .

[29]  J. Lord,et al.  Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. , 1999, Health economics.

[30]  J. Buendía,et al.  Cost of illness of RSV infection in a middle-income tropical country. , 2021, The Turkish journal of pediatrics.

[31]  J. Buendía.  [Attitudes, knowledge and beliefs of patient about anti-hypertensive drugs]. , 2012, Biomedica : revista del Instituto Nacional de Salud.